Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|November 19, 2015
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocolsRachael Hough, Robert Danby, Nigel Russell, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Haematologica|February 16, 2019
Durable remissions in <i>TCF3-HLF</i> positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantationBrice Mouttet, Luciana Vinti, Philip Ancliff, et al.
Blood|August 9, 2013
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR studyFranco Locatelli, Alessandro Crotta, Annalisa Ruggeri, et al.
Lancet (London, England)|July 31, 2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialRob Pieters, Martin Schrappe, Paola De Lorenzo, et al.
Pediatric Pulmonology|September 3, 2009
Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanismsMohammad Sawal, Marta Cohen, Jose E Irazuzta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Bone Marrow Transplantation|March 24, 2020
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kalwak, Monika Mielcarek, Katharine Patrick, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|November 19, 2015
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocolsRachael Hough, Robert Danby, Nigel Russell, et al.
Blood|August 7, 2009
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocolMarieke H van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
British Journal of Clinical Pharmacology|November 20, 2024
Impact of treosulfan exposure on clinical outcome after allogeneic stem cell transplantation in children: A substudy of 2 phase 2 trialsKrzysztof Kalwak, Ajay Vora, Peter Bader, et al.
Haematologica|February 16, 2019
Durable remissions in <i>TCF3-HLF</i> positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantationBrice Mouttet, Luciana Vinti, Philip Ancliff, et al.
Blood|August 9, 2013
Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: a EUROCORD, EBMT, EWOG-MDS, CIBMTR studyFranco Locatelli, Alessandro Crotta, Annalisa Ruggeri, et al.
Lancet (London, England)|July 31, 2007
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trialRob Pieters, Martin Schrappe, Paola De Lorenzo, et al.
Pediatric Pulmonology|September 3, 2009
Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanismsMohammad Sawal, Marta Cohen, Jose E Irazuzta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2022
Outcomes of Childhood Noninfant Acute Lymphoblastic Leukemia With 11q23/<i>KMT2A</i> Rearrangements in a Modern Therapy Era: A Retrospective International StudyAndishe Attarbaschi, Anja Möricke, Christine J Harrison, et al.
Bone Marrow Transplantation|March 24, 2020
Treosulfan-fludarabine-thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignanciesKrzysztof Kalwak, Monika Mielcarek, Katharine Patrick, et al.
Leukemia|December 22, 2022
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trialClaire Schwab, Ruth E Cranston, Sarra L Ryan, et al.
Pageof 17